The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

Recruiting

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid TumorsThe Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

Sponsor:

VastBiome

Code:

NCT05037825

Conditions

Non-Small-Cell Lung Carcinoma

Malignant Melanoma

Renal Cell Carcinoma

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Checkpoint Inhibitor, Immune

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by VastBiome on 2022-04-27.